Exelixis
EXEL
#1690
Rank
A$17.99 B
Marketcap
A$66.84
Share price
-0.02%
Change (1 day)
21.62%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company